Six Top Predictions for Biotech in 2024

Summary: In a Fireside Chat during the 2024 JP Morgan Healthcare Conference, Catalent President & CEO Alessandro Maselli shared his predictions for 2024 and his thoughts on the top risks and opportunities in Biotech with Endpoints News Editor John Carroll. They covered a wide range of topics: the future of biopharma, the funding landscape, M&A trends and other industry topics emerging as the industry looks towards the next wave of innovation. If you missed this insightful discussion about what may impact the industry in the year ahead and the importance of being agile and flexible to meet the challenges, now is your chance to view it.

Click below to watch the video of this thoughtful conversation certain to leave you with some intriguing takeaways.